Scotland sees soaring Parkinson’s rate

News

Author: Roisin McCormackPublished: 9 January 2020

Prep: Cook: Serves:

The number of drugs being prescribed for people living with Parkinson’s in Scotland, UK, has increased by more than a quarter.

National Health Service (NHS) figures, published by the Scottish Conservative party, show that the number of items being dispensed for the condition have leapt by 28% – from 260,355 in 2010 to 333,167 in 2019.

The sharp rise is thought to be a consequence of Scotland’s ageing population and has prompted calls from bodies, including Parkinson’s UK, for government action to ensure the NHS can cope with the increasing number of Parkinson’s cases.

Annie Macleod, director of Parkinson’s UK Scotland, said: “Over the next decade we expect to see numbers increase by a fifth.”

She added that reasons for such a spike could include “growing numbers of people living with more complex Parkinson’s, or changes to the ways that specialists are managing Parkinson’s”.

To read more on this topic click here.

Queen Elizabeth II honours UK university for Parkinson’s research

Last Month

Next Month

Go Back

Share this story

Comments

Resources & Tools

12 of the best domestic tools for people with Parkinson’s

A room-by-room roundup

Watch this amazing video of first Parkinson’s treatments from 1963

Uncovered: 50-year-old footage of earliest Parkinson’s treatment

Award-winning Parkinson’s inventor told to leave UK within 14 days

Inventor of life-changing Parkinson’s walking stick refused visa

Scientists at MIT uncover new clues about Parkinson’s disease

Neuroscientists at Massachusetts Institute of Technology (MIT), US, have developed new tools that could improve understanding of Parkinson’s disease. As part of a study, published in Science Advances, the tools were used on animals to investigate the relationship between two types of signals that are disrupted in Parkinson’s – dopamine signalling and beta-band oscillations (coordinated waves of electrical activity in the brain). The scientists found that while the animals performed certain tasks, beta-band oscillations increased while dopamine signalling declined in particular parts of the brain. Factors including an animal’s past experience and the reward value of a task also impacted the relationship between the two signals. Helen Schwerdt, a research scientist at MIT, said: “Considering electrical signals side by side with chemical signals is really important to understand how the brain works.” Ann Graybiel, a professor at MIT, added: “As these methods in neuroscience become more and more precise and…

People with Parkinson’s disease have a higher risk of dying from Covid-19, study finds

A new database study of around 80,000 Covid-19 patients has found that those living with Parkinson’s disease have a 30% higher risk of dying from the virus than those without the condition. The study – conducted by researchers at the University of Iowa Health Care, US – identified that Covid-19 patients with Parkinson’s disease were generally older, more likely to be male and less likely to be African American. As these factors could also affect the risk of death from Covid-19, the researchers adjusted their statistical models to account for differences in sex, age and race and found a significantly higher risk of dying from Covid-19 in the group of patients with Parkinson’s disease. Lead researcher Dr Nandakumar Narayanan said: “We recognise the limitations of this study; it is retrospective data from a single database, but we are confident that these data show that Parkinson’s disease is [an] independent risk factor…

BIAL enters the US and acquires “promising” Parkinson’s disease programmes

Portugal-based pharmaceutical company BIAL has launched a new research centre, BIAL Biotech, in Massachusetts, US, which will focus on genetically defined Parkinson’s disease. BIAL has also announced that it has acquired the Parkinson’s disease research programmes of Lysosomal Therapeutics Inc, as well as its research and development team and clinical programme for LTI-291 – a therapy designed to treat a genetic form of the condition. António Portela, executive president of BIAL, said: “Our entry into the US with the creation of BIAL Biotech and the acquisition of the promising programmes from LTI, is a decisive step towards the fulfilment of our mission to contribute to improving the quality of life of people worldwide. “The development of this new research centre in the US, is a landmark of enormous relevance for us. We are investing in science and research, through our direct presence in one of the most important research hubs…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

Scotland sees soaring Parkinson’s rate

News

Author: Roisin McCormackPublished: 9 January 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Resources & Tools

12 of the best domestic tools for people with Parkinson’s

Global update

Watch this amazing video of first Parkinson’s treatments from 1963

Perspectives

Award-winning Parkinson’s inventor told to leave UK within 14 days

Scientists at MIT uncover new clues about Parkinson’s disease

People with Parkinson’s disease have a higher risk of dying from Covid-19, study finds

BIAL enters the US and acquires “promising” Parkinson’s disease programmes

{title}

Subscribe

Scotland sees soaring Parkinson’s rate

News

Author: Roisin McCormackPublished: 9 January 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Resources & Tools

12 of the best domestic tools for people with Parkinson’s

Global update

Watch this amazing video of first Parkinson’s treatments from 1963

Perspectives

Award-winning Parkinson’s inventor told to leave UK within 14 days

Scientists at MIT uncover new clues about Parkinson’s disease

People with Parkinson’s disease have a higher risk of dying from Covid-19, study finds

BIAL enters the US and acquires “promising” Parkinson’s disease programmes

{title}

Subscribe

Sign in